[PMBI/DRUG/LTD.-227/2026] open

Bureau of Pharma PSUs of India (BPPI)

Ref: PMBI/DRUG/LTD.-227/2026 · ID: 2026_BPPI_912868_1

Value: ₹50,00,000

Category Drugs and Pharmaceutical Products

AI summary

This tender provides details about the project including scope of work, estimated value, deadlines, and eligibility requirements.

Overview

The Bureau of Pharma PSUs of India (BPPI) has issued a limited e-tender for the supply of DC-92 (Doxycycline Capsules IP 100mg). The tender is identified by the reference number PMBI/DRUG/LTD.-227/2026 and has a total estimated value of ₹50,00,000. Bidders are invited to submit their proposals in accordance with the guidelines provided in the tender documents.

Scope / Work

The scope of work involves the supply of Doxycycline Capsules to PMBI. Bidders must refer to the tender documents for specific requirements and pre-qualification criteria. The contract type is item rate, and the work is expected to be completed within 30 days from the date of award.

Fees & EMD

There is no tender fee associated with this tender. However, an Earnest Money Deposit (EMD) of ₹1,00,000 is required, which is payable to the Office of PMBI in Delhi. EMD exemption is allowed under certain conditions, which bidders should verify. Payment can be made through various offline instruments including Demand Draft, NEFT, RTGS, Bankers Cheque, and Bank Guarantee.

Key Dates

  • Published Date: 12-Jun-2026 06:00 PM
  • Bid Submission Start Date: 13-Jun-2026 12:00 PM
  • Bid Submission End Date: 19-Jun-2026 05:00 PM
  • Bid Opening Date: 24-Jun-2026 04:00 PM
  • Document Download Start Date: 12-Jun-2026 06:00 PM
  • Document Download End Date: 19-Jun-2026 05:00 PM
  • Clarification Period: 12-Jun-2026 06:00 PM to 16-Jun-2026 05:00 PM

Bidders should ensure timely submission of their bids and may download necessary documents from the provided links.

AI insights

Risk factors

  • EMD size
  • tight timelines
  • bid validity of 60 days
  • no tender fee

Financials

Tender value ₹50,00,000
EMD amount ₹1,00,000 — payable to Office of PMBI at Delhi
Tender fee ₹0.00 — payable to Nil at Nil

Payment mode Offline

Timeline

Publish date 12 Jun 2026
Bid end 19 Jun 2026
Opening date 24 Jun 2026

Critical dates

From the portal detail page (all dates captured when available).

Bid Opening Date 24-Jun-2026 04:00 PM
Bid Submission End Date 19-Jun-2026 05:00 PM
Bid Submission Start Date 13-Jun-2026 12:00 PM
Clarification End Date 16-Jun-2026 05:00 PM
Clarification Start Date 12-Jun-2026 06:00 PM
Document Download / Sale End Date 19-Jun-2026 05:00 PM
Document Download / Sale Start Date 12-Jun-2026 06:00 PM
Published Date 12-Jun-2026 06:00 PM

Tender Documents

How tender documents work

Sign in and verify your email to use our viewer. You can open up to 5 different documents per UTC day (each file counts once). Archives (ZIP, RAR, etc.) are download only—no in-browser preview. Need a higher limit?

Name Size Type Action
BOQ_959364.xls 381.5 KB XLS
View document Sign-in required
LimitedTender227.pdf 1.07 MB PDF
View document Sign-in required

Work details

Location, category, and schedule for this procurement.

Location As per tender document
Category Drugs and Pharmaceutical Products
Period of work 30 days
Bid validity 60 days

Tender basics

Tender type Limited
Form of contract Item Rate
Tender category Goods
No. of covers 2
Organisation chain Bureau of Pharma PSUs of India (BPPI)||Head Office(Gurgaon) - BPPI
Source portal eprocure.gov.in

Covers (bid packets)

What to submit in each cover, as listed on the tender portal.

Cover no. Cover type Description Document type
1 Fee/PreQual/Technical NIT to tender document for the supply of drugs to PMBI. .pdf
Tender document for the supply of drugs to PMBI. .pdf
2 Finance BOQ for the supply of drugs to PMBI. .xls

Authority details

Inviting authority As per tender document
Address As per tender document
Payment instruments Offline (Demand Draft) , Offline (R-T-G-S) , Offline (NEFT) , Offline (Bankers Cheque) , Offline (Bank Guarantee)

Browse by tags

Jump to other tenders using these keywords.